Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10576
PUT
TTM Technologies
TTMI
$12.4B
| $181K | ﹤0.01% |
7,300
-22,700
| -76% | -$514K |
2023 Q1
7 quarters
|
|
|
BRDG
10577
CALL
DELISTED
Bridge Investment Group
BRDG
| $181K | ﹤0.01% |
21,500
+3,900
| +22% | +$38.3K |
2022 Q1
11 quarters
|
|
10578
PUT
1-800-Flowers.com
FLWS
$175M
| $181K | ﹤0.01% |
22,100
+14,400
| +187% | +$115K |
2020 Q2
18 quarters
|
|
10579
CALL
Stem
STEM
$40.4M
| $181K | ﹤0.01% |
14,970
+10,515
| +236% | +$90.5K |
2020 Q4
16 quarters
|
|
|
AMIX
10580
Autonomix Medical
AMIX
$6.13M
| $180K | ﹤0.01% |
+2,280
| New | +$403K |
2024 Q4
0 quarters
|
|
10581
PUT
iShares MSCI Pacific ex Japan ETF
EPP
$2.18B
| $180K | ﹤0.01% |
4,100
+3,900
| +1,950% | +$182K |
2022 Q3
9 quarters
|
|
10582
PUT
ProShares UltraShort MSCI Brazil Capped
BZQ
$1.93M
| $180K | ﹤0.01% |
2,350
+2,100
| +840% | +$128K |
2024 Q3
1 quarter
|
|
10583
Brilliant Earth
BRLT
$24.7M
| $180K | ﹤0.01% |
85,508
+71,795
| +524% | +$132K |
2024 Q1
3 quarters
|
|
|
CTO
10584
PUT
CTO Realty Growth
CTO
$771M
| $179K | ﹤0.01% |
9,100
-9,900
| -52% | -$195K |
2022 Q4
8 quarters
|
|
10585
CALL
Banco Santander
SAN
$195B
| $179K | ﹤0.01% |
39,300
+9,400
| +31% | +$45.2K |
2019 Q1
23 quarters
|
|
10586
CALL
Driven Brands
DRVN
$1.94B
| $179K | ﹤0.01% |
11,100
-17,300
| -61% | -$271K |
2022 Q4
8 quarters
|
|
10587
PTC
PTC
$21B
| $179K | ﹤0.01% |
+974
| New | +$185K |
2024 Q4
0 quarters
|
|
10588
PUT
iShares MSCI USA Quality Factor ETF
QUAL
$48.6B
| $178K | ﹤0.01% |
1,000
+200
| +25% | +$36.3K |
2021 Q4
12 quarters
|
|
10589
Spero Therapeutics
SPRO
$66.4M
| $178K | ﹤0.01% |
172,872
+91,447
| +112% | +$109K |
2024 Q2
2 quarters
|
|
|
OZEM
10590
CALL
Roundhill GLP-1 & Weight Loss ETF
OZEM
$54.8M
| $178K | ﹤0.01% |
7,300
-24,900
| -77% | -$670K |
2024 Q2
2 quarters
|
|
10591
CALL
Tootsie Roll Industries
TR
$2.83B
| $178K | ﹤0.01% |
5,835
-6,047
| -51% | -$179K |
2020 Q2
18 quarters
|
|
10592
CALL
Lindsay Corp
LNN
$1.17B
| $177K | ﹤0.01% |
1,500
-7,300
| -83% | -$907K |
2018 Q2
26 quarters
|
|
|
KRON
10593
DELISTED
Kronos Bio
KRON
| $177K | ﹤0.01% |
186,711
+99,510
| +114% | +$93.9K |
2020 Q4
16 quarters
|
|
10594
PUT
First Trust Natural Gas ETF
FCG
$672M
| $177K | ﹤0.01% |
7,200
-13,500
| -65% | -$333K |
2022 Q2
10 quarters
|
|
10595
CALL
ProShares Ultra NASDAQ Biotechnology
BIB
$88.2M
| $177K | ﹤0.01% |
3,500
+300
| +9% | +$17.8K |
2022 Q3
9 quarters
|
|
10596
PUT
Tenable Holdings
TENB
$4.3B
| $177K | ﹤0.01% |
4,500
-80,300
| -95% | -$3.33M |
2022 Q4
8 quarters
|
|
10597
PUT
Moog Inc Class A
MOG.A
$11.5B
| $177K | ﹤0.01% |
900
+200
| +29% | +$41.1K |
2023 Q2
6 quarters
|
|
10598
PUT
Brown-Forman Class A
BF.A
$12.4B
| $177K | ﹤0.01% |
4,700
+3,500
| +292% | +$151K |
2022 Q4
8 quarters
|
|
10599
Blue Ridge Bankshares
BRBS
$350M
| $177K | ﹤0.01% |
54,964
-50,015
| -48% | -$158K |
2023 Q2
6 quarters
|
|
|
EFC
10600
CALL
Ellington Financial
EFC
$1.5B
| $177K | ﹤0.01% |
14,600
-5,300
| -27% | -$65.5K |
2022 Q2
10 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.